Cardinal Health stock trades at EUR 212.40 below its 52-week high EUR 213.00
Published on 10/12/2026 at 16:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Cardinal Health stock was EUR 212.40 at Lang & Schwarz on October 12, 2026 at 4:15 p.m. CEST.
- The price stood EUR 0.20 above the Xetra close of EUR 212.20 on October 9, 2026.
- The EUR 130.05 to EUR 213.00 52-week range puts the stock 0.28 percent below its high.
- MarketBeat cited a USD 266.56 average analyst target and a Moderate Buy consensus from 19 analysts.
Cardinal Health stock traded at EUR 212.40 at Lang & Schwarz on October 12, 2026 at 4:15 p.m. CEST. That was EUR 0.20, or 0.09 percent, above the Xetra close of EUR 212.20 on October 9, 2026, keeping the euro quote close to its yearly peak.
Euro quote nears yearly high
The dated euro range ran from EUR 130.05 to EUR 213.00 on October 9, 2026. At EUR 212.40, Cardinal Health stood 0.28 percent below that 52-week high, while the bid was EUR 211.80 and the ask was EUR 213.00 at Lang & Schwarz.
The US listing supplied a separate market view. Cardinal Health was last at USD 237.23 on the NYSE on October 12, 2026 at 10:29 a.m. EDT, with a 52-week range of USD 151.87 to USD 258.30 and a market capitalization of USD 55.6 billion.
Valuation carries the next signal
The valuation data put Cardinal Health at a P/E ratio of 32.75 and a dividend yield of 0.01 percent on October 12, 2026. MarketBeat reported on October 9, 2026 that 19 analysts held a Moderate Buy consensus, including 16 Buy ratings and three Holds, with an average 12-month target of USD 266.56.
Against the USD 237.23 NYSE quote, that target sits 12.36 percent higher in the same currency. The comparison matters because the euro price is close to its 52-week high, while the US-dollar target still leaves a measurable gap between the latest quote and the analyst average.
Comparison with peers
Cardinal Health: plus 0.09 percent, P/E 32.75, market capitalization USD 55.6 billion
McKesson (NYSE, USD): plus 1.46 percent, P/E 25.47, market capitalization USD 111.5 billion
Cencora (NYSE, USD): plus 0.64 percent, P/E 24.19, market capitalization USD 63.4 billion
November results set the calendar
Simply Wall St lists November 5, 2026 as Cardinal Health's next earnings date, following the fiscal year ended June 30, 2026. The latest annual figures show revenue of USD 254.2 billion, net income attributable to common shareholders of USD 1.7 billion and diluted earnings per share of USD 7.23 for fiscal 2026.
Cardinal Health's next scheduled reporting date gives the valuation figures a defined calendar point. Until then, the market picture is a narrow gap to the euro 52-week high, a 0.09 percent premium to the October 9 Xetra close and a 12.36 percent difference between the NYSE quote and the analyst average target.
The further course of trading is shown by the continuously updated real-time quote of Cardinal Health stock.
Cardinal Health stock facts
- Company: Cardinal Health, Inc.
- ISIN: US14149Y1082
- Ticker: CAH
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 12, 2026, 4:15 p.m. CEST): EUR 212.40
- Change versus Xetra close: plus 0.09 percent
- Xetra close (October 9, 2026): EUR 212.20
- Market capitalization: USD 55.6 billion (as of October 12, 2026)
- 52-week range: EUR 130.05-213.00 (as of October 9, 2026)
- Sector / Industry: Healthcare services and products
- Index membership: S&P 500
- Next earnings date: November 5, 2026
Market context: Market report S&P 500.
